Bg pattern

VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Ventolin 0.5 mg/ml Solution for Injection

salbutamol

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Ventolin 0.5 mg/ml Solution for Injection and what is it used for
  2. What you need to know before you use Ventolin 0.5 mg/ml Solution for Injection
  3. How to use Ventolin 0.5 mg/ml Solution for Injection
  4. Possible side effects
  5. Storage of Ventolin 0.5 mg/ml Solution for Injection
  1. Contents of the pack and further information

1. What is Ventolin 0.5 mg/ml Solution for Injection and what is it used for

Ventolin belongs to a group of medicines called bronchodilators. It relaxes the muscles of the walls of the small air passages in the lungs. This helps to open up the air passages and makes it easier to breathe, relieving wheezing, coughing, chest tightness, and shortness of breath.

Ventolin is indicated for the relief of severe bronchospasm associated with asthma or chronic bronchitis and for the treatment of status asthmaticus.

Ventolin injection is indicated for adults and adolescents.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Ventolin 0.5 mg/ml Solution for Injection

Do not use Ventolin 0.5 mg/ml Solution for Injection

  • if you are allergic to salbutamol or any of the other ingredients of this medicine (listed in section 6).
  • Non-intravenous preparations of Ventolin should not be used to stop premature labor or threatened abortion.

Warnings and Precautions

Consult your doctor or pharmacist before starting to use Ventolin if:

  • you have had to stop using this or any other medicine for the treatment of this condition due to allergy or any other problem
  • you have high blood pressure
  • you have hyperthyroidism (increased activity of the thyroid gland)
  • you have a history of heart problems such as rapid or irregular heartbeat or angina (chest pain)
  • you have low levels of potassium in your blood
  • you have diabetes mellitus (Ventolin may increase blood sugar levels)
  • you have lactic acidosis (increased production of lactic acid)
  • you are taking xanthine derivatives (such as theophylline) or steroids to treat asthma
  • you are taking diuretics, which are sometimes used to treat high blood pressure or heart problems.

Your doctor will monitor your potassium levels if you are taking xanthine derivatives, steroids, or diuretics.

  • Consult your doctor if you think you may have any of these problems.

Sometimes this medicine may not be suitable and your doctor may want to change it for another one.

Symptoms to be aware of

High doses of this medicine can occasionally produce a condition known as lactic acidosis. You should be aware of the appearance of certain symptoms while taking this medicine to reduce the risk of any problems. See "Symptoms to be aware of" in section 4.

Using Ventolin 0.5 mg/ml Solution for Injection with other medicines

Tell your doctor or pharmacist that you are taking, have recently taken, or might take any other medicines (e.g., treatments to eliminate fluids, any other type of bronchodilator tablets, steroids...), including those obtained without a prescription.

Also, inform your doctor if you are being treated with non-selective beta-blockers (mainly used for the treatment of heart rhythm disorders), such as propranolol, as these should not normally be administered with salbutamol.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, or think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

If it is necessary to administer Ventolin during pregnancy or breastfeeding, your doctor will carefully weigh the benefits and potential risks based on the severity of the clinical condition.

Driving and Using Machines

No studies have been conducted on the ability to drive and use machines.

Important Information about Some of the Ingredients of Ventolin 0.5 mg/ml Solution for Injection

This medicine contains less than 23 mg (1 mmol) of sodium per ampoule; it is essentially "sodium-free".

Use in Athletes

This medicine contains salbutamol, which can produce a positive result in doping tests.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to use Ventolin 0.5 mg/ml Solution for Injection

Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Ventolin injection is usually administered by a doctor or practitioner. It can be administered under the skin (subcutaneously), directly into a vein (intravenously), or into a muscle (intramuscularly).

The recommended dose administered subcutaneously or intramuscularly is 1 ampoule of 0.5 mg (500 micrograms).

The recommended dose administered intravenously is 0.25 mg (250 micrograms) injected very slowly.

Your doctor will indicate the duration of your treatment with Ventolin. Do not stop treatment before.

If you use more Ventolin 0.5 mg/ml Solution for Injection than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.

At high doses as well as in overdose, an increase in lactic acid levels in the blood has been identified, which can cause difficulty breathing and hyperventilation.

If you forget to use Ventolin 0.5 mg/ml Solution for Injection

Do not use a double dose to make up for forgotten doses.

4. Possible Side Effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Symptoms to be aware of

The following adverse reactions are very rare (may affect less than 1 in 10,000 patients) but very serious. Contact your doctor immediatelyif you experience any of these symptoms. Stop using Ventolin.

Allergic Reactions:are very rare in patients using Ventolin. They include:

  • sudden onset of wheezing or chest tightness
  • swelling of eyelids, face, or lips
  • skin rash (hives) or urticaria anywhere on the body
  • sudden feeling of weakness or dizziness (may lead to collapse or loss of consciousness).

Lactic Acidosis: a very rare side effect of Ventolin administered intravenously is the increase in lactic acid in the blood (lactic acidosis). This affects more often patients with severe kidney problems. The symptoms of lactic acidosis include:

  • rapid breathing, difficulty breathing
  • feeling cold
  • stomach pain, nausea, and vomiting.

The following side effects are associated with salbutamol, classified by organ system, frequency, and system.

The meaning of the terms used to describe the frequency of side effects is as follows: very common (may affect more than 1 in 10 patients), common (may affect up to 1 in 10 patients), uncommon (may affect up to 1 in 100 patients), rare (may affect up to 1 in 1,000 patients), and very rare side effects (may affect up to 1 in 10,000 patients).

Tell your doctor if you have any of the following symptoms:

Immune System Disorders

Very rare: hypersensitivity reactions including angioedema (skin reactions with redness, swelling, and itching), urticaria, bronchospasm (narrowing of the bronchial walls with decreased air intake), hypotension, and collapse.

Metabolism and Nutrition Disorders

Rare: hypokalemia (low potassium levels in the blood).

Therapy with beta-2 agonists, such as salbutamol, may lead to potentially serious hypokalemia.

Very rare: lactic acidosis.

Very rare cases of lactic acidosis have been reported in patients receiving salbutamol intravenously or by nebulization for the treatment of acute asthma exacerbations.

Nervous System Disorders

Very common: tremor.

Common: headache.

Very rare: hyperactivity.

Cardiac Disorders

Very common: tachycardia (increased heart rate), palpitations.

Rare: cardiac arrhythmias, including atrial fibrillation, supraventricular tachycardia, and extrasystoles (heart rhythm disorders).

Although the exact frequency is unknown, some people may occasionally experience chest pain (due to heart problems such as angina). Tell your doctor if you develop these symptoms while being treated with salbutamol, but do not stop taking it unless your doctor tells you to.

Vascular Disorders

Rare: peripheral vasodilation (dilation of peripheral blood vessels).

Respiratory, Thoracic, and Mediastinal Disorders

Uncommon: pulmonary edema (fluid accumulation in the lungs).

Gastrointestinal Disorders

Very rare: nausea, vomiting.

Musculoskeletal and Connective Tissue Disorders

Common: muscle cramps.

Injury, Poisoning, and Procedural Complications

Very rare: mild pain or stinging sensation in the case of intramuscular administration of the undiluted solution.

Reporting of Side Effects:

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Ventolin 0.5 mg/ml Solution for Injection

Keep this medicine out of the sight and reach of children.

Do not store above 30°C.

Store in the outer carton to protect from light.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the Pack and Further Information

Composition of Ventolin 0.5 mg/ml Solution for Injection

  • The active substance is salbutamol (as salbutamol sulfate). Each 1 ml ampoule contains 0.5 mg (500 micrograms) of salbutamol.
  • The other ingredients are sodium chloride, sulfuric acid or sodium hydroxide (for pH adjustment), and water for injections.

Appearance of the Product and Contents of the Pack

Ventolin injection is a sterile normal saline solution. Each pack contains 5 or 6 ampoules of 1 ml.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

GlaxoSmithKline, S.A.

P.T.M. C/ Severo Ochoa, 2

28760 Tres Cantos (Madrid)

Tel: +34 900 202 700

[email protected]

Manufacturer:

GlaxoSmithKline Manufacturing S.p.A.

Strada Provinciale Asolana, 90 -43056 San Polo di Torrile (Parma) Italy

Date of Last Revision of this Leaflet: October 2024

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

-------------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals

Dosage

Adults

Subcutaneous and intramuscular route: the normal dose is 1 ampoule with 0.5 mg (500 micrograms) at a rate of 8 micrograms/kg. The dose can be repeated every 4 hours if necessary.

Intravenous route: the normal dose is 0.25 mg (250 micrograms) at a rate of 4 micrograms/kg injected very slowly. If necessary, the dose can be repeated.

Use in Children

Safety and efficacy have not been established in children under 12 years of age.

In children 12 years and older: use the same dose as in the adult population.

Method of Administration

Ventolin injection can be diluted to facilitate administration. The only suitable solvents are: water for injections, sodium chloride injection solution, glucose injection solution, or sodium chloride and glucose injection solution.

Any unused mixtures of Ventolin 0.5 mg/ml Solution for Injection for fluid perfusion should be discarded 24 hours after preparation.

Whenever possible, oxygen administration is recommended in conjunction with Ventolin injection, mainly in hypoxic patients.

Do not mix in the same syringe with other medicines.

Instructions for Opening the Ventolin Injection Ampoule:

The ampoules have a "One Point Cut" (UPC) opening system and should be opened following the instructions below:

  • Hold the lower part of the ampoule with one hand, as indicated in Figure 1.
  • Place the other hand on the upper part of the ampoule, positioning the thumb on the colored point and pressing, as indicated in Figure 2.

Hand holding a transparent glass ampoule with a marked top and a perforated stopper

Figure 1

Hand holding an auto-injector with the thumb pressing the activation button and the fingers holding the device

Figure 2

The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION

Discuss questions about VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION?
VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION?
The active ingredient in VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION is salbutamol. This information helps identify medicines with the same composition but different brand names.
How much does VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION cost in pharmacies?
The average pharmacy price for VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION is around 2.19 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION?
VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION is manufactured by Glaxosmithkline S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to VENTOLIN 0.5 mg/ml INJECTABLE SOLUTION?
Other medicines with the same active substance (salbutamol) include ALDOBRONQUIAL 2 mg/5 ml SYRUP, VENTOLIN 2 mg/5 ml SYRUP, TERBASMIN 0.3 mg/ml ORAL SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media